Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized double-blind placebo-controlled crossover trial of human alpha-1 antitrypsin in fibromyalgia
2005-004830-42Phase 2Active
- Sponsor
- Grifols
- Start
- Jun 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alpha-1-proteinase inhibitor in fibromyalgia (FM) (2 arms), sponsored by Grifols. Primary endpoint: Primary clinical efficacy endpoint. Started Jun 2006; status: active.
02
Drugs
alpha-1-proteinase inhibitor
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2005-004830-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004830-42.